anthonyyazdaniml/gliner-biomed-balanced-curated-corpus huggingface dataset:
&lt;P&gt;PROBLEM TO BE SOLVED: To obtain a deodorant derived from a natural product, stably exhibiting excellent deodorant effects on various kinds of odorous substances, usable for deodorizing a wide range such as foods and drinks, feeds or various kinds of wastes and safely usable even by administration into a living body or application to the living body without adverse effects.  &lt;P&gt;SOLUTION: A yeast cell wall fraction obtained by removing soluble intramicrobial cell components from a yeast subjected to an enzymic treatment or a non-enzymic treatment is used as the deodorant for the various kinds of odorous substances. The deodorant is derived from the natural product and is safe and can safely be used even by administration into the living body or application to the living body. The odorous substances can be deodorized in the body or from the interior of the body by the administration or application without the adverse effects. The deodorant stably exhibits the deodorant effects on the various kinds of odorous substances and excellent deodorant effects can be obtained by the application to the wide range such as foods and drinks, feeds or various kinds of wastes.  &lt;P&gt;COPYRIGHT: (C)2006,JPO&amp;NCIPI
The invention discloses a kind of oat instant food of nutrition and health care, comprise the following steps：S1. pomelo peel and sugarcane soaking cooking；S2. sprouted unpolished rice boiling；S3. oat is crushed；S4. pomelo peel, sprouted unpolished rice and oat fermentation saccharification, obtain mixing saccharified liquid；S5. black fungus extract solution is prepared；S6. saccharified liquid and black fungus extract solution mixed fermentation are mixed, alcohol fermented beer is made；S7. the acetic acid bacteria culture fluid of volume 6 ~ 8% is accessed in alcohol fermented beer, cavings is added and wheat bran is fermented, obtain fermenting grain；S8. by fermenting grain ageing, squeezing, oat vinegar magma is obtained；S9. required according to finished product vinegar, adjust the acidity of oat vinegar magma, sterilizing is canned, obtains the oat instant food of nutrition and health care.The present invention can be convenient for people to quote, while can also help people&#39;s preventing hypertension and alleviate blood pressure rise phenomenon by the way that the raw materials such as pomelo peel, oat, brown rice are brewed into vinegar.
Procedure for the manufacture of a soluble antiseptico iodado of application in cutaneous affections and of other types. 100 grams of polyinyl pyrolrolone are dissolved in 300 grams of chlorophorm heated up to 60 deg. C. Apparatus is dissolved 13&#39;&#39;5 grams of iodine in 200 ml of chloroform. It is added in iodine dissolution on the polyvinyl pyridine one which maintains the mixture at 50 deg. C. The chlorophorm is evaporated and the mass that remains is dismunched by physical methods until reaching the desired size, which endes the process. (Machine-translation by Google Translate, not legally binding)
1,221,241. Detergent composition. CINCINNATI MILLING MACHINE CO. 1 Feb., 1968 [1 Feb., 1967; 9 Jan., 1968], No. 5275/68. Heading C5D. A detergent composition causing reduced skin irritation comprises a mildness additive of formula Y-R-Y&lt;SP&gt;1&lt;/SP&gt; wherein R is a divalent organic radical containing a chain of at least 15 atoms between the open valences, a majority of which are carbons, and a cyclic group of at least 5 carbons, and is (A) a hydrocarbon radical, (B) an ester radical of a cyclic dicarboxylic acid and a polyol, or (C) an amide radical of a cyclic dicarboxylic acid and a polyamine, and wherein Y and Y&lt;SP&gt;1&lt;/SP&gt; are polar groups containing carbon, nitrogen, oxygen, phosphorus, sulphur, or combinations thereof, said additive or its salt being liquid or soluble or colloidally dispersible in aqueous media, the polar groups of the mildness additive being stable and compatible with those of the detergent in aqueous media, the weight ratio of said additive to detergent being 0À005-10. R may be a C 15-80  hydrocarbon radical, and may be derived from the polymerized ethylenically unsaturated C 12-26  fatty acids. R may be a polyester radical derived by the reaction of a polyoxyalkylene glycol containing 1-30 oxyalkylene units, said alkylene groups having from 2-4 carbons with a dimer of a C 12-26  fatty acid, benzene dicarboxylic acid, a dihydrophthalic acid, a tetrahydrophthalic acid, or a cyclohexane dicarboxylic acid. R may alternatively be an amide radical derived by the reaction of a dimer of a C 12-26  fatty acid, benzene dicarboxylic acid, a dihydrophthalic acid, a tetrahydrophthalic acid, or a cyclohexane dicarboxylic acid with an alkanolamine containing 2-4 carbons. The degree of polymerization of polyester or polyamide is 1-10. The polar groups Y, Y&lt;SP&gt;1&lt;/SP&gt; may be hydroxyl, carboxyl, carboxyl salt, amino, substituted amino, amido, substituted amido, ester, sulphate, sulphonate, phosphate, phosphonate, sulphate salt, sulphonate salt, phosphate salt, or quaternary ammonium salt groups. 10-80% by weight of the composition may consist of builders and other adjuvants.
315,777. Hampshire, F. W., and Hampshire &amp; Co. (1927), Ltd., F. W. April 16, 1928. Linings and internal fittings.-A receptacle A, of circular or oval section, for volatile inhalants or smelling salts is provided with a diaphragm A&lt;2&gt; of plaster of Paris or like porous material through which the liquid diffuses. The diaphragm A&lt;2&gt; is supported upon a flange A&lt;3&gt; within the container and may be formed by pouring pasty plaster of Paris upon a cardboard disc supported on the flange after the insertion of the liquid. Alternatively the receptacle may be provided with a porous lining formed integrally with the diaphragm, the liquid being introduced into the space so formed either before completion of the diaphragm or by percolation through the latter. The receptacle is closed, when not in use, by a screw or friction cap B.
The invention comprises nuclearly sulphonated 1 - carboxy - 3 - monocyclic aryl - benzo-[f]-quinolines and their water-soluble salts, which may be prepared by bringing together at an elevated temperature a monocyclic aryl aldehyde, pyruvic acid, and a 2-naphthylamino sulphonic acid in presence of sufficient water to effect ready reaction, and in particular the water-soluble salts of compounds of the formula &lt;FORM:0698995/IV (b)/1&gt; wherein R is hydrogen or benzoyl and X is hydrogen or chlorine. An alkaline agent such as alkali metal or ammonium carbonates or bicarbonates may be present during the preparation.  The compounds are suitable as light filter dyes.  In examples (1) sodium 2-napthylamine-6-sulphonate is reacted with pyruvic acid and salicylaldehyde and the carboxy group of the product converted to its lithium salt with lithium carbonate, or to its ammonium or triethanolamine salts, or the hydroxy group is benzoylated with benzoyl chloride; (2) sodium 2-amino-8-naphthol-6-sulphonate is reacted with pyruvic acid and benzaldehyde or anisaldehyde; (3) 2-amino-5-naphthol-7-sulphonic acid is reacted with benzaldehyde, pyruvic acid and sodium carbonate; (4) sodium 2-naphthylamine-6-sulphonate is reacted with pyruvic acid and benzaldehyde, 2-hydroxy - 5 - chlorbenzaldehyde, anisaldehyde, o-anisaldehyde, or o-chlorbenzaldehyde.ALSO:The invention comprises nuclearly sulphonated 1 - carboxy - 3- monocyclic aryl - benzo(f)-quinolines and their water-soluble salts, which may be prepared by bringing together at an elevated temperature a monocyclic aryl aldehyde, pyruvic acid, and a 2-naphthylamine sulphonic acid in presence of sufficient water, to effect ready reaction and in particular the water-soluble salts of compounds of the formula &lt;FORM:0698995/IV (c)/1&gt; wherein R is hydrogen or benzoyl and X is hydrogen or chlorine. An alkaline agent such as alkali metal or ammonium carbonates or bicarbonates may be present during the preparation.  The compounds are suitable as light filter dyes.  In examples: (1) sodium 2-naphthylamine-6-sulphonate is reacted with pyruvic acid and salicylaldehyde and the carboxy group of the product converted to its lithium salt with lithium carbonate, or to its ammonium or triethanolamine salts, or the hydroxy group is benzoylated with benzoyl chloride; (2) tne sodium 2-amino-8-naphthol-6-sulphonate is reacted with pyruvic acid and benzaldehyde or anisaldehyde; (3) 2-amino-5-naphthol-7-sulphonic acid is reacted with benzaldehyde, pyruvic acid and sodium carbonate; (4) sodium 2 - naphthylamine - 6 - sulphonate is reacted with pyruvic acid and benzaldehyde, 2-hydroxy-5-chlorbenzaldehyde, anisaldehyde, o-anisaldehyde, or o-chlorbenzaldehyde.
Provided is a system providing a solution for improving prescription drug compliance monitoring and compliance. Prescription drug compliance monitoring may be achieved by using patient&#39;s electronic device to initiate secure digital imaging. Medications may be dispensed in containers with pre-printed encoded unique identifiers and markings. The patient may use the digital camera in their smart phone to take a picture of the dispensed blister pack which may be processed and analyzed. Analysis may include assessment of the number of pills taken from and remaining in the uniquely identified blister pack. Package identification and consumption information may then be linked with other prescription information to determine if the observed rate of use is compliant with the legal prescription and to document that the imaged medication package is the same as the dispensed medication package. Data may also be linked with pharmacologic and clinical data to categorize risk and urgency of misuse.
Methods for treating sleep disorders and for reducing a risk associated with developing a sleep disorder in patients via therapeutic renal neuromodulation and associated systems are disclosed herein. Sympathetic nerve activity can contribute to several cellular and physiological conditions associated with sleep disorders as well as an increased risk of developing a sleep disorder. One aspect of the present technology is directed to methods for improving a patient&#39;s calculated risk score corresponding to a sleep disorder status in the patient. Other aspects are directed to reducing a likelihood of developing a sleep disorder in patients presenting one or more sleep disorder risk factors. Renal sympathetic nerve activity can be attenuated to improve a patient&#39;s sleep disorder status or risk of developing a sleep disorder. The attenuation can be achieved, for example, using an intravascularly positioned catheter carrying a therapeutic assembly configured to use, e.g., electrically-induced, thermally-induced, and/or chemically-induced approaches to modulate the renal sympathetic nerve.
NEW MATERIAL:A compound of formula I (R&lt;1&gt;-R&lt;3&gt; are H, halogen, OH which may be protected, nitro, carboxyl, lower alkyloxy or lower acyloxy; R&lt;4&gt; is H, -CH=CH-CH3; n is 0 or 1) and a salt thereof. EXAMPLE:2-Hydroxy-3,5-dibromophenylbutenone. USE:A drug. An effective component for delayed allergy remedies. The usage thereof is 10mg-5g/day as the effective component, when the drug is administered as an ointment. The ointment is suitably applied to an affected portion over one-several times. PREPARATION:The compound of formula I is obtained by reacting a substituted benzaldehyde of formula II with acetone of formula III in the presence of a basic catalyst such as NaOH at 0-100 deg.C for 0.5-48hr in excess acetone or an inert solvent as a reaction solvent.
. The study\&amp;#39;s sample size will be 26 participants. Inclusion criteria for this study will be: Diagnosed Autistic between ages 4-10 years, Diagnosed Autistic Children, Treatment was given to each of the participants for 3 days a week and for 8 weeks. Inclusion criteria were all gender with the age group of 4-10 years, participants diagnosed cases of Autism spectrum disease with Toe Walking and their exclusion criteria were suspected but undiagnosed cases of ASD, the presence of any limb deformities , autistic children with MR, and unwillingness of participant or parents to be a part of the study. An RCT included 26 diagnosed autistic children as per inclusion criteria the subjects were divided into two groups, i.e., group A and B, the group A was given MET with Stationary bicycling whereas Group B was given MET without Stationary Bi-Cycling participants were clinically examined. Dynamometer, foot posture Index, Observational Gait Scale, and Parent report of percentage of time toe walking,
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a method which enables him or her to easily apply an external poultice to an intended site by himself or herself, and to provide its product configuration.  &lt;P&gt;SOLUTION: A double-faced adhesive tape contains a substrate with tabs, and it is characterized by that the double-faced adhesive tape is adhered on the surface of the external poultice (which is not coated with a medicine) and covered by a peeling paper. This invention is available not only general external poultices such as adhesive skin patches, but also small poultices such as magnetic therapeutic apparatuses, element therapeutic apparatuses, acupuncture and moxibustion instruments, and the like. This makes a patient apply to an affected part such as a neck, a shoulder, and a back which are difficult to be adhered because of weak substrates by himself or herself easily. Additionally, his or her feeling of hands and fingers are available to make it possible to approach the intended affected part currently and smoothly. If the configuration is only for adhesives, it is used for stomatitic poultices effectively.  &lt;P&gt;COPYRIGHT: (C)2008,JPO&amp;INPIT
NEW MATERIAL:A compound expressed by formula I (R1 to R3 are lower alkyl or phenyl; R4 is H, lower acyl or formula II). EXAMPLE:N&lt;2&gt;-tert-Butyldimethylsilyl-9-(tert-butyldimethylsilyloxyetho xymethyl) guanine. USE:An antiviral agent. PREPARATION:9-(2-Hydroxyethoxymethyl)guanine expressed by formula III is reacted with a halogenosilyl compound expressed by formula IV (X is halogen) in the presence of a basic catalyst in a suitable solvent (e.g. aromatic hydrooarbons or ethers) to afford the compound expressed by formula I (R4 is R or formula II). An acid anhydride is reacted with the resultant compound expressed by formula I (R4 is H) to provide the compound expressed by formula I (R4 is lower acyl).
&lt;P&gt;PROBLEM TO BE SOLVED: To provide more effective anti-HCV (Hepatitis C Virus) treatment.  &lt;P&gt;SOLUTION: The present invention relates to compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in the patient by administering a composition comprising a compound of this invention. The invention further relates to processes for preparing these compounds.  &lt;P&gt;COPYRIGHT: (C)2009,JPO&amp;INPIT
Disclosed herein are methods for the production of mutant bacteriophages with altered host range. Additionally, disclosed herein are methods and systems for rapid detection of microorganisms such as &lt;i&gt;Listeria spp&lt;/i&gt;. in a sample. A genetically modified bacteriophage is also disclosed which comprises an indicator gene in the late gene region. The specificity of the bacteriophage, such as &lt;i&gt;Listeria&lt;/i&gt;-specific bacteriophage, allows detection of a specific microorganism, such as &lt;i&gt;Listeria spp&lt;/i&gt;. and an indicator signal may be amplified to optimize assay sensitivity.
This invention proposes a smart dining table which provides placement for a dinner plate and has a table mat, a camera component, a plurality of weight sensors, a nutrition determination module, and a video interactive module. The camera component is used to capture images of dishes placed on the dinner plate. The weight sensors are used to sense the weight of the dinner plate. A tablecloth storage component has a storage box and a tablecloth. The advantage of this invention is that the camera component can identify the dishes on the dinner plate and the weight sensors can also sense the user&#39;s food intake, and then transmit the same to the nutrition determination module for calculation through an artificial intelligence engine to calculate the nutritional content of each dish on the dinner plate and to accurately monitor the user&#39;s eating status. Furthermore, in addition to providing an interactive eating environment, the video interactive module also provides remote care functions.
PURPOSE:To obtain the subject compound useful as a therapeutic agent effective for osteoporosis caused by dissolution of collagen, having excellent inhibitory action on cathepsin L. CONSTITUTION:A physiologically active peptide-based compound of formula I (R is H or -OH) such as cathestatin A of formula II. Cathestatin A has the following physical properties. Appearance: white powder. Molecular formula: C17H23N3O5. Molecular weight: 349. Mass spectrum: (SI-Mass)350(M+H)&lt;+&gt;. Solubility: soluble in water, DMSO and acetic acid, insoluble in benzene, ethyl acetate and chloroform. Color reaction: positive to ninhydrin, etc. The compound of formula I is obtained by culturing a strain SCRC-OB16 (FERM-P-13,390), a newly separated one from a sponge in a sea area of Misaki at Yokosuka city in Kanagawa Prefecture, Japan, under an aerobic condition at pH6-7 at 20-30 deg.C for 2-10 days.
PURPOSE: To obtain a (meth)acryloylaminoalkyl carboxylate capable of accomplishing a strong adhesive bond as an adhesive component for a collagen- containing material. CONSTITUTION: This formulation as an adhesive component comprises a compound of the formula (R&lt;1&gt; is H or methyl; R&lt;2&gt; is methylene or ethylene; R&lt;3&gt; is methyl or ethyl), e.g. methacryloylaminomethyl acetate, and, if necessary, an additive such as an initiator, a solvent and a filler. A photo initiator (e.g. camphorquinone) inducing a free-radical polymerization under an action of ultraviolet rays, visible rays or laser rays is preferable as the initiator, and a volatile organic solvent is preferable as the solvent. The preparation can contain further a coactivator (e.g. an amine and a trialkylamine) promoting the polymerization reaction, and a (meth)acrylic ester or a carbonyl compound, preferably a 2-6C aldehyde or ketone for forming a crosslinking bond.
The utility model discloses an oral ulcer paster fixing device relates to oral ulcer paster auxiliary device technical field, has solved the oral ulcer paster and can take place relative movement with patient&#39;s oral ulcer, leads to the oral ulcer paster can not contact with patient&#39;s oral ulcer, can not play the technical problem of the effect of treatment oral ulcer. The oral ulcer paster fixing device comprises a clamping piece. The clamping piece comprises an inner connecting rod, an outer connecting rod and an elastic restraining section. The clamping piece is located the internal connection pole bottom and is provided with the interior clamping piece with lip inner wall contact, and interior clamping piece is located lip inner wall one side and is provided with the cavity that matches with the canker sore paster, and the cavity is located lip inner wall one side and is provided with the opening. The elastic restraint section can clamp the utility model on the lips of the patient. When the dental ulcer patch is clamped, the dental ulcer patch is aligned to the dental ulcer position of a patient, so that the dental ulcer patch is fixed to the dental ulcer position of the patient, and the dental ulcer patch is prevented from moving.
FIELD: medicine.SUBSTANCE: invention refers to medicine, radiation diagnostics and can be used for 3D modeling for 3D printing when planning resections of pancreas in patients with tumor involvement. It is followed by CT with intravenous bolus contrast enhancement of hepatopancreatibiliary zone by low-dose protocol to obtain phases of maximum density gradient in arteries and veins of portal system. Obtained CT images are loaded into Myrian program and anatomical segmentation of image is performed. In the first phase of contrast amplification, the arterial bed is separated, in the second phase – the portal system. 3D area of interest is created and an automatic &#34;hepatic artery&#34; protocol is used to isolate the arteries of the celiac-mesenterial system, as well as an automatic protocol for the portal vein &#34;portal vein, solid filter&#34; separation. Pancreas is separated into a phase of maximum gradient with surrounding healthy tissues. Further, the tumor is recovered using the three-dimensional interpolation method with delineation of the formation at several levels depending on the size and shape. Obtained areas of interest: arteries, veins, and tumor are displayed on one screen of three-dimensional rendering called &#34;surface area of interest&#34; by transportation of missing object from other phase of contrast amplification. Obtained virtual model is evaluated for presence of errors in the image by comparison with axial CT sections. Further, the obtained three-dimensional model is stored in segmentation format and loaded into the Materialize program to create a three-dimensional printing file STL-file. Obtained file is loaded into 3D print program FlashPrint and sent to 3D printer FlashForge Dreamer. On the obtained three-dimensional model, supporting structures which were created automatically in FlashPrint are deleted.EFFECT: method provides planning of pancreatic resections in patients with tumor involvement by printing a three-dimensional model of the region of interest.1 cl, 11 dwg, 1 ex
PURPOSE:To obtain the titled powder having excellent whiteness and filling effect in resins and being suitable as a material for plastic teeth in dental use by heating silicon nitride powder having high conversion rate to alpha-form at high temp. in the presence of gaseous chlorine, then heating further at high temp. in the presence of N2. CONSTITUTION:Silicon nitride powder having &gt;=30% rate of conversion to alpha- form, which is prepd. by the nitridation of metallic Na is heated at &gt;=1,100 deg.C in the presence of gaseous chlorine to remove iron contained therein completely and to whiten the product. Then, the treated silicon nitride is heated at &gt;=1,200 deg.C in the presence of gaseous N2 to improve the whiteness further, and target white silicon nitride powder is obtd. Obtd. silicon nitride powder has superior suitability for filling resin and &gt;=ca.80 deg. Hunter whiteness. Therefore, it is suitable for use for other teeth besides the molars when it is used for plastic dental material.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a method of inducing human hair growth in a non-human animal by transplanting mixed cells including human cells, to provide a non-human animal having human hair grown by the method and to provide a screening method using the animal.  &lt;P&gt;SOLUTION: In the skin of a non-human animal, hair growth is induced from the hair follicle structure including human-originating cells. Dermal papilla cells, epidermal cells and dermal fibroblasts (at least one of them originates from a human) are mixed and the mixture is transplanted to the skin of a non-human animal whereby the growth of human hair is in vivo induced on the skin. A non-human animal that has human hair grown on its skin. In addition, screening process for hair growth factor and the like including the process that the factors to be tested are brought into contact with the non-human animals and the evaluation method for the activity of the factors.  &lt;P&gt;COPYRIGHT: (C)2003,JPO